Vidrala (VID) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Revenue for 2024 reached nearly €1.6 billion, with EBITDA at €454 million and EPS of €8.85, including a €50 million capital gain from the Italy sale.
Strategic refocus on three core regions: divestment from Italy, integration of a large UK bottling facility, and entry into Brazil.
Business exceeded expectations for EBITDA and cash generation despite a challenging macroeconomic environment and soft demand.
Portfolio reshaped by major industrial investments in Europe and new manufacturing/logistics facilities in Portugal and Brazil.
Positioned for future growth with a solid financial base and readiness for further investment.
Financial highlights
Total sales for 2024 were €1,588.3 million, up 1.9% year-over-year; organic growth at 0.2% on constant currency and comparable scope.
EBITDA rose 15.3% to €454 million, with organic growth of 10.5%; EBITDA margin expanded to 28.6%.
Net profit increased 27.8% to €298.3 million; EPS up 28.5% to €8.85.
Free cash flow generation was €206 million, representing 13% of sales.
Net debt reduced to €248.3 million, with a leverage ratio of 0.6x annual EBITDA.
Outlook and guidance
EBITDA for 2025 is expected to remain at similar or higher levels, with free cash flow generation around €200 million considered safe.
CapEx for 2025 is projected to be slightly higher than 2024, at around 11% of sales, with investments in sustainability and verticalization.
Management remains committed to financial discipline and long-term strategic guidelines focused on customer, cost, and capital.
Focus remains on competitive optimization in Iberia, value-added services in the UK, and progress in Brazil.
Official guidance to be announced at the AGM.
Latest events from Vidrala
- 2025 saw lower sales but higher margins, reduced debt, and a 15% dividend increase proposal.VID
Q4 202525 Feb 2026 - H1 2024 saw stable margins, strong cash flow, and strategic moves for future growth.VID
Q2 20243 Feb 2026 - EBITDA margin hit 27.8% on €1.2B+ sales, EPS rose 26%, and guidance remains robust.VID
Q3 202418 Jan 2026 - EBITDA margin rose to 28.1% and leverage improved despite lower sales and profit.VID
Q1 202527 Dec 2025 - Margins rose to 29.3% and leverage fell to 0.3x EBITDA despite lower sales.VID
Q3 202529 Oct 2025 - EBITDA margin rose and leverage improved, despite lower sales and profit.VID
Q2 202524 Jul 2025